Published in Blood on June 15, 1997
Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer (2001) 1.72
Stat5 signaling specifies basal versus stress erythropoietic responses through distinct binary and graded dynamic modalities. PLoS Biol (2012) 1.59
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc Natl Acad Sci U S A (2001) 1.20
Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases. World J Gastroenterol (2004) 1.08
Recent Departures in the Synthesis of Peptides and Glycopeptides. Tetrahedron (2009) 1.07
Measurement of reticulocyte hemoglobin content to diagnose iron deficiency in Saudi children. Eur J Pediatr (2006) 0.95
Probing the stability of nonglycosylated wild-type erythropoietin protein via reiterative alanine ligations. Proc Natl Acad Sci U S A (2012) 0.92
Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study. Drug Des Devel Ther (2013) 0.87
Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery. Adv Mater (2016) 0.84
Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia. Clin Cancer Res (2008) 0.83
Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment. Haematologica (2010) 0.76
Structural Identification of a Non-Glycosylated Variant at Ser126 for O-Glycosylation Site from EPO BRP, Human Recombinant Erythropoietin by LC/MS Analysis. Mol Cells (2015) 0.75
Traumatic Optic Neuropathy - A Conundrum. J Clin Diagn Res (2016) 0.75
Erythropoietin in liver cirrhosis: two questions without answers. World J Gastroenterol (2005) 0.75
Successful treatment of a hemodialyzed patient with pure red cell aplasia associated with epoetin beta pegol therapy with cyclosporine. CEN Case Rep (2015) 0.75
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature (2000) 7.46
Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood (2001) 6.35
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell (1999) 4.69
Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat Med (1995) 2.76
Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology (2000) 2.44
E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol Cell (2000) 2.21
Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nat Genet (1998) 1.98
Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest (1997) 1.87
Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell (1996) 1.85
Regulation of erythrocyte cation and water content in sickle cell anemia. Science (1986) 1.65
Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice. Proc Natl Acad Sci U S A (1999) 1.57
cDNA cloning and functional characterization of the mouse Ca2+-gated K+ channel, mIK1. Roles in regulatory volume decrease and erythroid differentiation. J Biol Chem (1998) 1.56
Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl J Med (1990) 1.47
Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits. Shock (1998) 1.43
Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response. Am J Med (1994) 1.43
Reinterpretation of the RACTK1 K+ channel. Am J Physiol (1997) 1.40
A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood (1996) 1.39
[HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)]. Pediatr Med Chir (1994) 1.39
Erythropoietin, iron, and erythropoiesis. Blood (2000) 1.36
Thawing fresh frozen plasma in a microwave oven. A comparison with thawing in a 37 degrees C waterbath. Am J Clin Pathol (1992) 1.34
Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3- exchanger. J Biol Chem (1998) 1.25
Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest (1985) 1.22
Anemia in hemodialysis patients: variables affecting this outcome predictor. J Am Soc Nephrol (1997) 1.21
Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood (1994) 1.19
Cell volume, K transport, and cell density in human erythrocytes. Am J Physiol (1987) 1.19
Mild spherocytosis and altered red cell ion transport in protein 4. 2-null mice. J Clin Invest (1999) 1.19
A dominant negative mutant of the KCC1 K-Cl cotransporter: both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity. J Biol Chem (2001) 1.19
Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. J Clin Invest (1994) 1.18
Novel AE1 mutations in recessive distal renal tubular acidosis. Loss-of-function is rescued by glycophorin A. J Clin Invest (1998) 1.17
The antifungal antibiotic, clotrimazole, inhibits Cl- secretion by polarized monolayers of human colonic epithelial cells. J Clin Invest (1996) 1.08
A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica (2000) 1.06
Duplication of 10 nucleotides in the erythroid band 3 (AE1) gene in a kindred with hereditary spherocytosis and band 3 protein deficiency (band 3PRAGUE). J Clin Invest (1994) 1.05
Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias. Blood (1994) 1.03
Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest (1997) 1.02
Voltage-activated cation transport in human erythrocytes. Am J Physiol (1989) 1.01
Characterization of adult alpha- and beta-globin genes in the zebrafish. Blood (1997) 0.99
Cation transport in mouse erythrocytes: role of K(+)-Cl- cotransport in regulatory volume decrease. Am J Physiol (1995) 0.99
Hemoglobin variants and activity of the (K+Cl-) cotransport system in human erythrocytes. Blood (1992) 0.99
Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood (1999) 0.98
Bradykinin and vasopressin stimulate Na+-K+-Cl- cotransport in cultured endothelial cells. Am J Physiol (1986) 0.94
Endothelins activate Ca(2+)-gated K(+) channels via endothelin B receptors in CD-1 mouse erythrocytes. Am J Physiol (1999) 0.94
Complement induces a transient increase in membrane permeability in unlysed erythrocytes. J Clin Invest (1988) 0.93
Inhibition of maxi-K currents in ferret portal vein smooth muscle cells by the antifungal clotrimazole. Am J Physiol (1997) 0.92
Modes of operation and variable stoichiometry of the furosemide- sensitive Na and K fluxes in human red cells. J Gen Physiol (1986) 0.92
Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease. Br J Haematol (2000) 0.90
Cellular effects of hydroxyurea in Hb SC disease. Br J Haematol (1997) 0.89
Management training for pathology residents. II. Experience with a focused curriculum. Am J Clin Pathol (1994) 0.88
Furosemide-sensitive Na and K fluxes in human red cells. Net uphill Na extrusion and equilibrium properties. J Gen Physiol (1986) 0.88
Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy. Blood (1996) 0.88
Maximum urine concentrating ability in children with Hb SC disease: effects of hydroxyurea. Am J Hematol (2000) 0.88
Elevation of red cell sodium-lithium countertransport in hyperlipidemias. Life Sci (1985) 0.88
Cerebrospinal fluid plasminogen activator inhibitor-1: a prognostic factor in posthaemorrhagic hydrocephalus. Acta Paediatr (1997) 0.88
Serine/threonine protein phosphatases and regulation of K-Cl cotransport in human erythrocytes. Am J Physiol (1999) 0.87
Mouse K-Cl cotransporter KCC1: cloning, mapping, pathological expression, and functional regulation. Am J Physiol (1999) 0.87
Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia. J Clin Invest (1997) 0.86
The antifungal imidazole clotrimazole and its major in vivo metabolite are potent blockers of the calcium-activated potassium channel in murine erythroleukemia cells. J Membr Biol (1997) 0.86
Effect of metabolic depletion on the furosemide-sensitive Na and K fluxes in human red cells. J Membr Biol (1985) 0.86
Resistance to osmotic lysis in BXD-31 mouse erythrocytes: association with upregulated K-Cl cotransport. Am J Physiol (1996) 0.85
Hydroxyurea and erythropoietin therapy in sickle cell anemia. Semin Oncol (1992) 0.85
Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative Group. Vox Sang (1990) 0.85
Observations on certain enzyme activites of normal human red cells treated with sulfhydryl compounds. Blood (1966) 0.85
Properties of the Na+-K+ pump in human red cells with increased number of pump sites. J Clin Invest (1987) 0.85
Stimulation of human erythrocyte K-Cl cotransport and protein phosphatase type 2A by n-ethylmaleimide: role of intracellular Mg++. J Membr Biol (2000) 0.84
Sulfhydryl oxidation and activation of red cell K(+)-Cl- cotransport in the transgenic SAD mouse. Am J Physiol (1995) 0.83
Ca2+-activated K+ efflux limits complement-mediated lysis of human erythrocytes. J Clin Invest (1989) 0.83
HPLC measurement, blood distribution, and pharmacokinetics of oral clotrimazole, potentially useful antisickling agent. Clin Chem (1995) 0.83
Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse. Blood (1996) 0.81
Dietary magnesium supplementation ameliorates anemia in a mouse model of beta-thalassemia. Blood (1997) 0.81
Cross-reactivity between the first and second segregant series of the HLA system. Tissue Antigens (1976) 0.81
Deferiprone therapy in homozygous human beta-thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity. J Lab Clin Med (1999) 0.81
Degree of agreement in plasma fibrinogen among two functional and one immunonephelometric assays. Am J Clin Pathol (1997) 0.81
Plasma exchange for mushroom poisoning. Transfusion (1978) 0.81
The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin. Br J Haematol (1997) 0.80
Plasminogen activator inhibitor-1: defining characteristics in the cerebrospinal fluid of newborns. J Pediatr (2000) 0.80
The effect of hemoglobin A and S on the volume- and pH-dependence of K-Cl cotransport in human erythrocyte ghosts. J Membr Biol (1999) 0.79
Compensatory eythropoiesis during routine autologous blood donation. Transfusion (1998) 0.79
Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline I1 and I2 binding sites. Eur J Pharmacol (1996) 0.78
Voltage-activated cation permeability in high-potassium but not low-potassium red blood cells. Am J Physiol (1990) 0.78
HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives. Tissue Antigens (1989) 0.77
The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia. Haematologica (1998) 0.77
Prevention of red cell dehydration: a possible new treatment for sickle cell disease. Pediatr Pathol Mol Med (2003) 0.77
[Consensus conference. Saving blood: which are still the doubts and the problems?]. Minerva Anestesiol (1994) 0.77
K-Cl cotransport modulation by intracellular Mg in erythrocytes from mice bred for low and high Mg levels. Am J Physiol Cell Physiol (2001) 0.77
Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes. Int J Sports Med (2000) 0.77
A high-performance liquid chromatographic assay for the determination of itraconazole concentration using solid-phase extraction and small sample volume. Ther Drug Monit (1995) 0.76
New approach to preoperative autologous blood donation (PABD) Int J Artif Organs (2000) 0.76
A case of paroxysmal cold haemoglobinuria with unusual serological findings. Haematol Lat (1966) 0.75
Flow-cytometric analysis of erythrocytes and reticulocytes in congenital dyserythropoietic anaemia type II (CDA II): value in differential diagnosis with hereditary spherocytosis. Clin Lab Haematol (2001) 0.75
Cephalothin-treated normal red cells: a new type of PNH-like cells. Experientia (1968) 0.75
Lithium-sodium countertransport in erythrocytes of normal and hypertensive subjects. Relationship with age and plasma renin activity. Hypertension (1983) 0.75
AET-treated lymphocytes; their use in the lymphocytotoxicity reaction. Tissue Antigens (1971) 0.75
[Relations between renin activity and vascular complications of arterial hypertension]. Minerva Cardioangiol (1982) 0.75
Practical methods to improve transfusion safety by using novel blood unit and patient identification systems. Am J Clin Pathol (1997) 0.75
[Multiple renal arteries and arterial hypertension: a review of 337 renal arteriography cases]. Minerva Cardioangiol (1980) 0.75
Multiple arterial stenoses in chronic ergot toxicity. N Engl J Med (1984) 0.75
Structure and genetic polymorphism of the mouse KCC1 gene. Biochim Biophys Acta (2000) 0.75